Clinical Trial Update: Chaigui Longmu Ejiao Paste for Ischemic Heart Disease [Phase 2]

View source ↗

Summary

Clinical trial update for Chaigui Longmu Ejiao Paste in ischemic heart disease shows a Phase 2 study that is not yet recruiting, sponsored by Longhua Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Chaigui Longmu Ejiao Paste

Snippet

Sponsor: Longhua Hospital | Conditions: Ischemic Heart Disease | Phase 2 | Status: NOT_YET_RECRUITING